271 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Statements" and "Use of Non-GAAP Financial Information."
Environmental, Social & Governance (ESG)
As a leading biopharmaceutical company, Bristol … ("SEC") filings, public conference calls, presentations and webcasts. We may also use social media channels to communicate with our investors
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
on sustainability and social impact Important component of attracting specialized talent Rewards creation of incremental shareholder value Provides a mix of short … company’s portfolio Long-Term Growth Potential Qualitative Overlay ESG Scorecard Aligned to our commitments on sustainability and social impact Rewards
8-K
EX-4.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
by the laws of the State of New York.
A-10
ASSIGNMENT FORM
I or we assign and transfer this Security to:
Insert social security or other identifying number … with and governed by the laws of the State of New York.
B-9
ASSIGNMENT FORM
I or we assign and transfer this Security to:
Insert social security or other
424B5
db2p6tqo30x1jqy
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
gq57oxqm14er
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
mxjnckvsgd5n3
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
ogzbc tib
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
56alhgvhtiwb
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
x5lxhs ij
25 Jan 24
Third party tender offer statement
8:13am